Evidence map›Paper›PMID 25148837›Full record

ArticleEuropean heart journal2014

The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology.

Paulus Kirchhof, Karin R Sipido, Martin R Cowie, Thomas Eschenhagen, Keith A A Fox, Hugo Katus, Stefan Schroeder, Heribert Schunkert, Silvia Priori, ESC CRT R&D and European Affairs Work Shop on Personalized Medicine

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Observational
  5. Review
  6. Big Data in Cardiology: State-of-Art and Future Prospects.Frontiers in cardiovascular medicine · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Precision Medicine in Interventional Cardiology.Interventional cardiology (London, England) · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paulus Kirchhof
Karin R Sipido
Martin R Cowie
Thomas Eschenhagen
Keith A A Fox
Hugo Katus
Stefan Schroeder
Heribert Schunkert
Silvia Priori
ESC CRT R&D and European Affairs Work Shop on Personalized Medicine

Funding

British Heart Foundation FS/13/43/30324
6 · The paper itself

Abstract

There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.

Indexed as

Precision MedicineBiomarkersCardiovascular DiseasesClinical Trials as TopicDiagnostic ImagingDiffusion of InnovationEvidence-Based MedicineGenomicsHumansNeeds AssessmentPatient-Centered CareRisk AssessmentBiomarkers

Identifiers

PMID25148837
PMCPMC4258224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.